Delivery Order SPE2DB22D9112-SPE2DB24FE6XM
Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $5.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,092.04 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025....
- This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,269.76 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 31, 2024, with an ultimate completion date of August 1, 2024. The contract is for the delivery of 4565399768 - TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,092.04 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, with a period of performance through September 5, 2024. DMS Pharmaceutical Group Inc. holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $1,092.04 for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
- This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,981.11 award is for the delivery of 4565691711 CAPVAXIVE 0.5 ML SYRINGE 0.5ML medical supplies, with a completion date of September 4, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,628 contract is for the delivery of meningococcal group vaccines and medical supplies, with a period of performance through June 2025. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue...
- This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The $6,535.22 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of May 13, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA), has awarded a firm fixed-price delivery order contract worth $1,147.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Tetanus/Diphtheria vaccines and medical supplies to support the recurring medical needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing...